MiR‐92b‐3p‐TSC1 axis is critical for mTOR signaling‐mediated vascular smooth muscle cell proliferation induced by hypoxia

Abstract

Pulmonary artery smooth muscle cells (PASMCs) undergo proliferation by the mammalian target of rapamycin (mTOR) signaling pathway under hypoxia. Hypoxia induces expression of a specific set of microRNAs (miRNAs) in a variety of cell types. We integrated genomic analyses of both small non‐coding RNA and coding transcripts using next‐generation sequencing (NGS)‐based RNA sequencing with the molecular mechanism of the mTOR signaling pathway in hypoxic PASMCs. These analyses revealed hypoxia‐induced miR‐92b‐3p as a potent regulator of the mTOR signaling pathway. We demonstrated that miR‐92b‐3p directly targets the 3′ UTR of a negative regulator in the mTOR signaling pathway, TSC1. mTOR signaling and consequent cell proliferation were promoted by enforced expression of miR‐92b‐3p but inhibited by knocking down endogenous miR‐92b‐3p. Furthermore, inhibition of miR‐92b‐3p attenuated hypoxia‐induced proliferation of vascular smooth muscle cells (VSMCs). Therefore, this study elucidates a novel role of miR‐92b‐3p as a hypoxamir in the regulation of the mTOR signaling pathway and the pathological VSMC proliferative response under hypoxia. These findings will help us better understand the miRNA‐mediated molecular mechanism of the proliferative response of hypoxic VSMCs through the mTOR signaling pathway.